Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders

References

• Robinson-Shelton A, Malow BA. Sleep Disturbances in Neurodevelopmental Disorders. Curr Psychiatry Rep. 2016 Jan;18(1):6.
   PubMed Web of Science ®Google Scholar
• van de Wouw E, Evenhuis HM, Echteld MA. Prevalence, associated factors and treatment of sleep problems in adults with intellectual disability: a systematic review. Res Dev Disabil. 2012;33(4):1310–1332.
   PubMed Web of Science ®Google Scholar
• Goldman SE, Bichell TJ, Surdyka K, et al. Sleep in children and adolescents with Angelman syndrome: association with parent sleep and stress. J Intellect Disabil Res JIDR. 2012;56(6):600–608.
   PubMed Web of Science ®Google Scholar
• Gail Williams P, Sears LL, Allard A. Sleep problems in children with autism. J Sleep Res. 2004;13(3):265–268.
   PubMed Web of Science ®Google Scholar
• Gringras P, Gamble C, Jones AP, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ. 2012;345:e6664.
   PubMedGoogle Scholar
• Johnson KP, Malow BA. Sleep in children with autism spectrum disorders. Curr Neurol Neurosci Rep. 2008;8(2):155–161.
   PubMed Web of Science ®Google Scholar
• Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, et al. Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res. 2008;17(2):197–206.
   PubMed Web of Science ®Google Scholar
• Melke J, Goubran Botros H, Chaste P, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13(1):90–98.
   PubMed Web of Science ®Google Scholar
• Mindell JA, Emslie G, Blumer J, et al. Pharmacologic management of insomnia in children and adolescents: consensus statement. Pediatrics. 2006;117(6):e1223–1232.
   PubMed Web of Science ®Google Scholar
• Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53(9):783–792.
   PubMed Web of Science ®Google Scholar
• Grigg-Damberger M, Ralls F. Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders. Curr Opin Pulm Med. 2013;19(6):616–625.
   PubMed Web of Science ®Google Scholar
• Cortese S, Faraone SV, Konofal E, et al. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2009;48(9):894–908.
   PubMed Web of Science ®Google Scholar
• Quine L. Sleep problems in children with mental handicap. J Ment Defic Res. 1991;35(Pt 4):269–290.
   PubMedGoogle Scholar
• Cuomo BM, Vaz S, Lee EAL, et al. Effectiveness of Sleep-Based Interventions for Children with Autism Spectrum Disorder: A Meta-Synthesis. Pharmacotherapy. 2017;37(5):555–578.
   PubMed Web of Science ®Google Scholar
• Taira M, Takase M, Sasaki H. Sleep disorder in children with autism. Psychiatry Clin Neurosci. 1998;52(2):182–183.
   PubMed Web of Science ®Google Scholar
• Okawa MSH. Sleep disorders in mentally retarded and brain- impaired children. In: Guilleminault C, editor. Sleep and its Disorders in Children. New York, NY: Raven Press; 1987. p. 269–290.
   Google Scholar
• Jan JE, Owens JA, Weiss MD, et al. Sleep hygiene for children with neurodevelopmental disabilities. Pediatrics. 2008;122(6):1343–1350.
   PubMed Web of Science ®Google Scholar
• Honaker SM, Meltzer LJ. Bedtime Problems and Night Wakings in Young Children: an Update of the Evidence. Paediatr Respir Rev. 2014;15(4):333–339.
   PubMed Web of Science ®Google Scholar
• Angriman M, Caravale B, Novelli L, et al. Sleep in children with neurodevelopmental disabilities. Neuropediatrics. 2015;46(3):199–210.
   PubMed Web of Science ®Google Scholar
• Meltzer LJ, Mindell JA. Systematic review and meta-analysis of behavioral interventions for pediatric insomnia. J Pediatr Psychol. 2014;39(8):932–948.
   PubMed Web of Science ®Google Scholar
• Strategies to Improve Sleep in Children with Autism Spectrum Disorders. Autism Speaks Autism Treatment Network, [cited 2019 Sep 9]. https://vkc.mc.vanderbilt.edu/assets/files/resources/sleepasd.pdf
   Google Scholar
• Quick Tips. Improving Sleep for Children with Autism. Autism Speaks Autism Treatment Network. [cited 2019 Sep 9]. https://www.autismspeaks.org/sites/default/files/2018-09/Sleep%20Quick%20Tips.pdf
   Google Scholar
• Malow BA, Katz T, Reynolds AM, et al. Sleep Difficulties and Medications in Children With Autism Spectrum Disorders: A Registry Study. Pediatrics. 2016;137 Suppl 2:S98–104.
   PubMed Web of Science ®Google Scholar
• Beresford B, McDaid C, Parker A, et al. Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review. Health Technol Assess Winch Engl. 2018;22(60):1–296.
   Web of Science ®Google Scholar
• Pelayo R, Yuen K. Pediatric sleep pharmacology. Child Adolesc Psychiatr Clin N Am. 2012;21(4):861–883.
   PubMed Web of Science ®Google Scholar
• Hiscock H, Bayer J, Gold L, et al. Improving infant sleep and maternal mental health: a cluster randomised trial. Arch Dis Child. 2007;92(11):952–958.
   PubMed Web of Science ®Google Scholar
• Heussler H, Chan P, Price AMH, et al. Pharmacological and non-pharmacological management of sleep disturbance in children: an Australian Paediatric Research Network survey. Sleep Med. 2013 Feb;14(2):189–194.
   PubMed Web of Science ®Google Scholar
• Bruni O, Violani C, Luchetti A, et al. Di Donatella Valente C. The Sleep Knowledge of Pediatricians and Child Neuropsychiatrists. Sleep Hypnosis J Clin Neurosci Psychopathol. 2004;6(3):130–138.
   Google Scholar
• Owens JA, Rosen CL, Mindell JA, et al. Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey. Sleep Med. 2010;11(7):692–700.
   PubMed Web of Science ®Google Scholar
• Pelayo R, Dubik M. Pediatric sleep pharmacology. Semin Pediatr Neurol. 2008;15(2):79–90.
   PubMed Web of Science ®Google Scholar
• Kennaway DJ. Melatonin and development: physiology and pharmacology. Semin Perinatol. 2000;24(4):258–266.
   PubMed Web of Science ®Google Scholar
• Gobbi G, Comai S. Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep. Front Endocrinol. 2019;10:87.
   PubMed Web of Science ®Google Scholar
• Hartz I, Furu K, Bratlid T, et al. Hypnotic drug use among 0-17 year olds during 2004-2011: a nationwide prescription database study. Scand J Public Health. 2012;40(8):704–711.
   PubMed Web of Science ®Google Scholar
• Cortesi F, Giannotti F, Sebastiani T, et al. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J Sleep Res. 2012;21(6):700–709.
   PubMed Web of Science ®Google Scholar
• Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Res Dev Disabil. 2011;32(3):939–962.
   PubMed Web of Science ®Google Scholar
• Abdelgadir IS, Gordon MA, Akobeng AK. Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. Arch Dis Child. 2018;103(12):1155–1162.
   PubMed Web of Science ®Google Scholar
• Phillips L, Appleton RE. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol. 2004;46(11):771–775.
   PubMed Web of Science ®Google Scholar
• Braam W, Smits MG, Didden R, et al. Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol. 2009;51(5):340–349.
   PubMed Web of Science ®Google Scholar
• Braam W, Didden R, Smits MG, et al. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial. J Child Neurol. 2008;23(6):649–654.
   PubMed Web of Science ®Google Scholar
• Wasdell MB, Jan JE, Bomben MM, et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res. 2008;44(1):57–64.
   PubMed Web of Science ®Google Scholar
• McArthur AJ, Budden SS. Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol. 1998;40(3):186–192.
   PubMed Web of Science ®Google Scholar
• De Leersnyder H, de Blois MC, Vekemans M, et al. beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome. J Med Genet. 2001;38(9):586–590.
   PubMed Web of Science ®Google Scholar
• Van der Heijden KB, Smits MG, Van Someren EJW, et al. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int. 2005;22(3):559–570.
   PubMed Web of Science ®Google Scholar
• Van der Heijden KB, Smits MG, Van Someren EJW, et al. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007;46(2):233–241.
   PubMed Web of Science ®Google Scholar
• Smits MG, van Stel HF, van der Heijden K, et al. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2003;42(11):1286–1293.
   PubMed Web of Science ®Google Scholar
• Appleton RE, Jones AP, Gamble C, et al. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS). Health Technol Assess Winch Engl. 2012;16(40):i–239.
   PubMed Web of Science ®Google Scholar
• Goldman SE, Adkins KW, Calcutt MW, et al. Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. J Autism Dev Disord. 2014;44(10):2525–2535.
   PubMed Web of Science ®Google Scholar
• Cortese S, Brown TE, Corkum P, et al. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013;52(8):784–796.
   PubMed Web of Science ®Google Scholar
• Braam W, Keijzer H, Struijker Boudier H, et al. CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder? J Intellect Disabil Res JIDR. 2013;57(11):993–1000.
   PubMed Web of Science ®Google Scholar
• Braam W, van Geijlswijk I, Keijzer H, et al. Loss of response to melatonin treatment is associated with slow melatonin metabolism. J Intellect Disabil Res. 2010;54(6):547–555.
   PubMedGoogle Scholar
• van Geijlswijk IM, van der Heijden KB, Egberts ACG, et al. Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology (Berl). 2010;212(3):379–391.
   PubMed Web of Science ®Google Scholar
• Gringras P, Nir T, Breddy J, et al. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2017;56(11):948–957.e4.
   PubMed Web of Science ®Google Scholar
• Maras A, Schroder CM, Malow BA, et al. Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2018 Oct 11. DOI:10.1089/cap.2018.0020;.
   PubMed Web of Science ®Google Scholar
• McDonagh MS, Holmes R, Hsu F. Pharmacologic Treatments for Sleep Disorders in Children: A Systematic Review. J Child Neurol. 2019;34(5):237–247.
   PubMed Web of Science ®Google Scholar
• Bruni O, Alonso-Alconada D, Besag F, et al. Current role of melatonin in pediatric neurology: clinical recommendations. Eur J Paediatr Neurol. 2015;19(2):122–133.
   PubMed Web of Science ®Google Scholar
• Miyamoto A, Fukuda I, Tanaka H, et al. [Treatment with ramelteon for sleep disturbance in severely disabled children and young adults]. No Hattatsu Brain Dev. 2013;45(6):440–444.
   PubMedGoogle Scholar
• Mignot E, Taheri S, Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci. 2002;5 Suppl:1071–1075.
   PubMed Web of Science ®Google Scholar
• Thakkar MM. Histamine in the regulation of wakefulness. Sleep Med Rev. 2011;15(1):65–74.
   PubMed Web of Science ®Google Scholar
• Schnoes CJ, Kuhn BR, Workman EF, et al. Pediatric prescribing practices for clonidine and other pharmacologic agents for children with sleep disturbance. Clin Pediatr (Phila). 2006;45(3):229–238.
   PubMed Web of Science ®Google Scholar
• Russo RM, Gururaj VJ, Allen JE. The effectiveness of diphenhydramine HCI in pediatric sleep disorders. J Clin Pharmacol. 1976;16(5–6):284–288.
   PubMed Web of Science ®Google Scholar
• Merenstein D, Diener-West M, Halbower AC, et al. The trial of infant response to diphenhydramine: the TIRED study–a randomized, controlled, patient-oriented trial. Arch Pediatr Adolesc Med. 2006;160(7):707–712.
   PubMedGoogle Scholar
• France KG, Blampied NM, Wilkinson P. A multiple-baseline, double-blind evaluation of the effects of trimeprazine tartrate on infant sleep disturbance. Exp Clin Psychopharmacol. 1999;7(4):502–513.
   PubMed Web of Science ®Google Scholar
• Ottaviano S, Giannotti F, Cortesi F. The effect of niaprazine on some common sleep disorders in children. A double-blind clinical trial by means of continuous home-videorecorded sleep. Childs Nerv Syst. 1991;7(6):332–335.
   PubMed Web of Science ®Google Scholar
• Montanari G, Schiaulini P, Covre A, et al. Niaprazine vs chlordesmethyldiazepam in sleep disturbances in pediatric outpatients. Pharmacol Res. 1992;25 Suppl 1:83–84.
   PubMed Web of Science ®Google Scholar
• Dinndorf PA, McCabe MA, Frierdich S. Risk of abuse of diphenhydramine in children and adolescents with chronic illnesses. J Pediatr. 1998;133(2):293–295.
   PubMed Web of Science ®Google Scholar
• Baker AM, Johnson DG, Levisky JA, et al. Fatal diphenhydramine intoxication in infants. J Forensic Sci. 2003;48(2):425–428.
   PubMed Web of Science ®Google Scholar
• Magera BE, Betlach CJ, Sweatt AP, et al. Hydroxyzine intoxication in a 13-month-old child. Pediatrics. 1981;67(2):280–283.
   PubMed Web of Science ®Google Scholar
• Gringras P. When to use drugs to help sleep. Arch Dis Child. 2008 Nov;93(11):976–981.
   PubMed Web of Science ®Google Scholar
• Nguyen M, Tharani S, Rahmani M, et al. A review of the use of clonidine as a sleep aid in the child and adolescent population. Clin Pediatr (Phila). 2014;53(3):211–216.
   PubMed Web of Science ®Google Scholar
• Delbarre B, Schmitt H. Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol. 1971;13(3):356–363.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Biederman J, Spencer T. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1994;33(3):424–426.
   PubMed Web of Science ®Google Scholar
• Prince JB, Wilens TE, Biederman J, et al. Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adolesc Psychiatry. 1996;35(5):599–605.
   PubMed Web of Science ®Google Scholar
• Ingrassia A, Turk J. The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders–a case series. Eur Child Adolesc Psychiatry. 2005;14(1):34–40.
   PubMed Web of Science ®Google Scholar
• Ming X, Gordon E, Kang N, et al. Use of clonidine in children with autism spectrum disorders. Brain Dev. 2008;30(7):454–460.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Klein-Schwartz W, Colvin JM, et al. Toxic clonidine ingestion in children. J Pediatr. 2005;146(2):263–266.
   PubMed Web of Science ®Google Scholar
• Handen BL, Sahl R, Hardan AY. Guanfacine in children with autism and/or intellectual disabilities. J Dev Behav Pediatr JDBP. 2008;29(4):303–308.
   PubMed Web of Science ®Google Scholar
• Efron D, Lycett K, Sciberras E. Use of sleep medication in children with ADHD. Sleep Med. 2014;15(4):472–475.
   PubMed Web of Science ®Google Scholar
• Scahill L, McCracken JT, King BH, et al. Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. Am J Psychiatry. 2015;172(12):1197–1206.
   PubMed Web of Science ®Google Scholar
• Rugino TA. Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release. J Atten Disord. 2018;22(1):14–24.
   PubMed Web of Science ®Google Scholar
• Politte LC, Scahill L, Figueroa J, et al. A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures. Neuropsychopharmacol. 2018;43(8):1772–1778.
   PubMed Web of Science ®Google Scholar
• Minkel J, Krystal AD. Optimizing the Pharmacologic Treatment of Insomnia: current Status and Future Horizons. Sleep Med Clin. 2013 1;8(3):333–350.
   PubMedGoogle Scholar
• Owens JA. Update in pediatric sleep medicine. Curr Opin Pulm Med. 2011;17(6):425–430.
   PubMed Web of Science ®Google Scholar
• Arens R, Wright B, Elliott J, et al. Periodic limb movement in sleep in children with Williams syndrome. J Pediatr. 1998;133(5):670–674.
   PubMed Web of Science ®Google Scholar
• Thirumalai SS, Shubin RA, Robinson R. Rapid eye movement sleep behavior disorder in children with autism. J Child Neurol. 2002;17(3):173–178.
   PubMed Web of Science ®Google Scholar
• Zisapel N. Drugs for insomnia. Expert Opin Emerg Drugs. 2012;17(3):299–317.
   PubMed Web of Science ®Google Scholar
• Blumer JL, Findling RL, Shih WJ, et al. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/hyperactivity disorder in children 6 to 17 years of age. Pediatrics. 2009;123(5):e770–776.
   PubMed Web of Science ®Google Scholar
• Sangal RB, Blumer JL, Lankford DA, et al. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder. Pediatrics. 2014;134(4):e1095–1103.
   PubMed Web of Science ®Google Scholar
• Liskow B, Pikalov A. Zaleplon overdose associated with sleepwalking and complex behavior. J Am Acad Child Adolesc Psychiatry. 2004;43(8):927–928.
   PubMed Web of Science ®Google Scholar
• Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: pharmacology, Clinical Applications, and Discovery. Pharmacol Rev. 2018;70(2):197–245.
   PubMed Web of Science ®Google Scholar
• Rosenberg RP, Hull SG, Lankford DA, et al. A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter, Polysomnographic Study of Gabapentin in Transient Insomnia Induced by Sleep Phase Advance. J Clin Sleep Med. 2014 15;10(10):1093–1100.
   PubMed Web of Science ®Google Scholar
• Robinson AA, Malow BA. Gabapentin shows promise in treating refractory insomnia in children. J Child Neurol. 2013;28(12):1618–1621.
   PubMed Web of Science ®Google Scholar
• Bruni O, Angriman M, Luchetti A, et al. Leg kicking and rubbing as a highly suggestive sign of pediatric restless legs syndrome. Sleep Med. 2015;16(12):1576–1577.
   PubMed Web of Science ®Google Scholar
• Walsh JK. Drugs used to treat insomnia in 2002: regulatory-based rather than evidence-based medicine. Sleep. 2004 15;27(8):1441–1442.
   PubMed Web of Science ®Google Scholar
• Holmberg G. Sedative effects of maprotiline and amitriptyline. Acta Psychiatr Scand. 1988;77(5):584–586.
   PubMed Web of Science ®Google Scholar
• Ware JC, Brown FW, Moorad PJ, et al. Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients. Sleep. 1989;12(6):537–549.
   PubMed Web of Science ®Google Scholar
• Riemann D, Voderholzer U, Cohrs S, et al. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry. 2002;35(5):165–174.
   PubMed Web of Science ®Google Scholar
• Yeung W-F, Chung K-F, Yung K-P, et al. Doxepin for insomnia: A systematic review of randomized placebo-controlled trials. Sleep Med Rev. 2015;19:75–83.
   PubMed Web of Science ®Google Scholar
• Zell-Kanter M, Toerne TS, Spiegel K, et al. Doxepin toxicity in a child following topical administration. Ann Pharmacother. 2000;34(3):328–329.
   PubMed Web of Science ®Google Scholar
• Younus M, Labellarte MJ. Insomnia in children: when are hypnotics indicated? Paediatr Drugs. 2002;4:6.
   Google Scholar
• Wichniak A, Wierzbicka A, Jernajczyk W. Sleep and antidepressant treatment. Curr Pharm Des. 2012;18(36):5802–5817.
   PubMed Web of Science ®Google Scholar
• Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7(3):249–264.
   PubMedGoogle Scholar
• Posey DJ, Guenin KD, Kohn AE, et al. A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2001;11(3):267–277.
   PubMed Web of Science ®Google Scholar
• Bertisch SM, Herzig SJ, Winkelman JW, et al. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014 1;37(2):343–349.
   PubMed Web of Science ®Google Scholar
• Giannaccini G, Masala I, Palego L, et al. Melatonin and pro-hypnotic effectiveness of the antidepressant Trazodone: A preliminary evaluation in insomniac mood-disorder patients. Clin Biochem. 2016;49(15):1152–1158.
   PubMed Web of Science ®Google Scholar
• Pranzatelli MR, Tate ED, Dukart WS, et al. Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone. J Pediatr. 2005;147(3):372–378.
   PubMed Web of Science ®Google Scholar
• Bossini L, Coluccia A, Casolaro I, et al. Off-Label Trazodone Prescription: evidence, Benefits and Risks. Curr Pharm Des. 2015;21(23):3343–3351.
   PubMed Web of Science ®Google Scholar
• Allen BC, Fisher JW. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 1993;13(1):71–86.
   PubMed Web of Science ®Google Scholar
• Biban P, Baraldi E, Pettennazzo A, et al. Adverse effect of chloral hydrate in two young children with obstructive sleep apnea. Pediatrics. 1993;92(3):461–463.
   PubMed Web of Science ®Google Scholar
• Sheldon. Insomnia in Children. Curr Treat Options Neurol. 2001;3(1).
   PubMedGoogle Scholar
• Sezer T, Alehan F. Chloral hydrate versus hydroxyzine HCL for sedation prior to pediatric sleep EEG recording. Int J Neurosci. 2013;123(10):719–723.
   PubMed Web of Science ®Google Scholar
• Glaze DG. Childhood insomnia: why Chris can’t sleep. Pediatr Clin North Am. 2014;51(1):33–50.
   Google Scholar
• Fong CY, Tay CG, Ong LC, et al. Chloral hydrate as a sedating agent for neurodiagnostic procedures in children. Cochrane Database Syst Rev. 2017;03(11):CD011786.
   Google Scholar
• Masi G, Cosenza A, Millepiedi S, et al. Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study. CNS Drugs. 2009;23(6):511–521.
   PubMed Web of Science ®Google Scholar
• Capone GT, Goyal P, Grados M, et al. Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study. J Dev Behav Pediatr. 2008;29(2):106–116.
   PubMed Web of Science ®Google Scholar
• Meltzer LJ, Mindell JA, Owens JA, et al. Use of sleep medications in hospitalized pediatric patients. Pediatrics. 2007;119(6):1047–1055.
   PubMed Web of Science ®Google Scholar
• DeMartinis NA, Winokur A. Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol Disord Drug Targets. 2007;6(1):17–29.
   PubMedGoogle Scholar
• Thompson W, Quay TAW, Rojas-Fernandez C, et al. Atypical antipsychotics for insomnia: a systematic review. Sleep Med. 2016;22:13–17.
   PubMed Web of Science ®Google Scholar
• Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 15;13(2):307–349.
   PubMed Web of Science ®Google Scholar
• Tassniyom K, Paholpak S, Tassniyom S, et al. Quetiapine for primary insomnia: a double blind, randomized controlled trial. J Med Assoc Thail Chotmaihet Thangphaet. 2010;93(6):729–734.
   PubMedGoogle Scholar
• Golubchik P, Sever J, Weizman A. Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial. Clin Neuropharmacol. 2011;34(6):216–219.
   PubMed Web of Science ®Google Scholar
• Chow M, Cao M. The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress. Nat Sci Sleep. 2016;8:81–86.
   PubMed Web of Science ®Google Scholar
• Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8(3):171–181.
   PubMed Web of Science ®Google Scholar
• Kumar A, Chanana P, Choudhary S. Emerging role of orexin antagonists in insomnia therapeutics: an update on SORAs and DORAs. Pharmacol Rep PR. 2016;68(2):231–242.
   PubMed Web of Science ®Google Scholar
• Morairty SR, Revel FG, Malherbe P, et al. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PloS One. 2012;7(7):e39131.
   PubMed Web of Science ®Google Scholar
• Kishi T, Matsunaga S, Iwata N. Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. PloS One. 2015;10(8):e0136910.
   PubMed Web of Science ®Google Scholar
• Kawabe K, Horiuchi F, Ochi M, et al. Suvorexant for the Treatment of Insomnia in Adolescents. J Child Adolesc Psychopharmacol. 2017;27(9):792–795.
   PubMed Web of Science ®Google Scholar
• Prieto DI, Zehgeer AA, Connor DF. Use of Suvorexant for sleep regulation in an adolescent with early-onset bipolar disorder. J Child Adolesc Psychopharmacol. 2019;29(5):395.
   PubMed Web of Science ®Google Scholar
• Bennett T, Bray D, Neville MW. Suvorexant, a dual orexin receptor antagonist for the management of insomnia. P T Peer-Rev J Formul Manag. 2014;39(4):264–266.
   Google Scholar
• Hartmann E. Editorial: L-tryptophan: a possible natural hypnotic substance. JAMA. 1974 23;230(12):1680–1681.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Kane JM, Reife R. Neuromuscular effects of monoamine oxidase inhibitors. J Clin Psychopharmacol. 1985;5(4):221–228.
   PubMed Web of Science ®Google Scholar
• Schneider-Helmert D, Spinweber CL. Evaluation of L-tryptophan for treatment of insomnia: a review. Psychopharmacology (Berl). 1986;89(1):1–7.
   PubMed Web of Science ®Google Scholar
• Hartmann E, Spinweber CL. Sleep induced by L-tryptophan. Effect of dosages within the normal dietary intake. J Nerv Ment Dis. 1979;167(8):497–499.
   PubMed Web of Science ®Google Scholar
• Hudson C, Hudson SP, Hecht T, et al. Protein source tryptophan versus pharmaceutical grade tryptophan as an efficacious treatment for chronic insomnia. Nutr Neurosci. 2005;8(2):121–127.
   PubMed Web of Science ®Google Scholar
• Hartmann E, Lindsley JG, Spinweber C. Chronic insomnia: effects of tryptophan, flurazepam, secobarbital, and placebo. Psychopharmacology (Berl). 1983;80(2):138–142.
   PubMed Web of Science ®Google Scholar
• Spinweber CL. L-tryptophan administered to chronic sleep-onset insomniacs: late-appearing reduction of sleep latency. Psychopharmacology (Berl). 1986;90(2):151–155.
   PubMed Web of Science ®Google Scholar
• Meolie AL, Rosen C, Kristo D, et al. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med. 2005 15;1(2):173–187.
   PubMed Web of Science ®Google Scholar
• España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep. 2011 1;34(7):845–858.
   PubMed Web of Science ®Google Scholar
• Imeri L, Mancia M, Bianchi S, et al. 5-Hydroxytryptophan, but not L-tryptophan, alters sleep and brain temperature in rats. Neuroscience. 2000;95(2):445–452.
   PubMed Web of Science ®Google Scholar
• Monti JM. Serotonin control of sleep-wake behavior. Sleep Med Rev. 2011;15(4):269–281.
   PubMed Web of Science ®Google Scholar
• Michelson D, Page SW, Casey R, et al. An eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan. J Rheumatol. 1994;21(12):2261–2265.
   PubMed Web of Science ®Google Scholar
• Klarskov K, Johnson KL, Benson LM, et al. Structural characterization of a case-implicated contaminant, “Peak X,” in commercial preparations of 5-hydroxytryptophan. J Rheumatol. 2003;30(1):89–95.
   PubMed Web of Science ®Google Scholar
• Williamson BL, Klarskov K, Tomlinson AJ, et al. Problems with over-the-counter 5-hydroxy-L-tryptophan. Nat Med. 1998;4(9):983.
   PubMed Web of Science ®Google Scholar
• Das YT, Bagchi M, Bagchi D, et al. Safety of 5-hydroxy-L-tryptophan. Toxicol Lett. 2004 15;150(1):111–122.
   PubMed Web of Science ®Google Scholar
• Ribeiro CA. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. Headache. 2000;40(6):451–456.
   PubMed Web of Science ®Google Scholar
• Ryan ND, Birmaher B, Perel JM, et al. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression. Depressed vs normal children. Arch Gen Psychiatry. 1992;49(11):843–851.
   PubMed Web of Science ®Google Scholar
• Cross DR, Kellermann G, McKenzie LB, et al. A randomized targeted amino acid therapy with behaviourally at-risk adopted children. Child Care Health Dev. 2011;37(5):671–678.
   PubMed Web of Science ®Google Scholar
• Kordas K, Siegel EH, Olney DK, et al. Maternal reports of sleep in 6-18 month-old infants from Nepal and Zanzibar: association with iron deficiency anemia and stunting. Early Hum Dev. 2008;84(6):389–398.
   PubMed Web of Science ®Google Scholar
• Kordas K, Siegel EH, Olney DK, et al. The effects of iron and/or zinc supplementation on maternal reports of sleep in infants from Nepal and Zanzibar. J Dev Behav Pediatr. 2009;30(2):131–139.
   PubMed Web of Science ®Google Scholar
• Kotagal S, Silber MH. Childhood-onset restless legs syndrome. Ann Neurol. 2004;56(6):803–807.
   PubMed Web of Science ®Google Scholar
• Picchietti DL, Stevens HE. Early manifestations of restless legs syndrome in childhood and adolescence. Sleep Med. 2008;9(7):770–781.
   PubMed Web of Science ®Google Scholar
• Abou-Khadra MK, Amin OR, Shaker OG, et al. Parent-reported sleep problems, symptom ratings, and serum ferritin levels in children with attention-deficit/hyperactivity disorder: a case control study. BMC Pediatr. 2013;13:217.
   PubMed Web of Science ®Google Scholar
• Cortese S, Konofal E, Bernardina BD, et al. Sleep disturbances and serum ferritin levels in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2009;18(7):393–399.
   PubMed Web of Science ®Google Scholar
• Dosman CF, Brian JA, Drmic IE, et al. Children with autism: effect of iron supplementation on sleep and ferritin. Pediatr Neurol. 2007;36(3):152–158.
   PubMed Web of Science ®Google Scholar
• Lane R, Kessler R, Buckley AW, et al. Evaluation of periodic limb movements in sleep and iron status in children with autism. Pediatr Neurol. 2015;53(4):343–349.
   PubMed Web of Science ®Google Scholar
• Youssef J, Singh K, Huntington N, et al. Relationship of serum ferritin levels to sleep fragmentation and periodic limb movements of sleep on polysomnography in autism spectrum disorders. Pediatr Neurol. 2013;49(4):274–278.
   PubMed Web of Science ®Google Scholar
• Blackmer AB, Feinstein JA. Management of sleep disorders in children with neurodevelopmental disorders: a review. Pharmacotherapy. 2016;36(1):84–98.
   PubMed Web of Science ®Google Scholar
• Muscogiuri G, Barrea L, Scannapieco M, et al. The lullaby of the sun: the role of vitamin D in sleep disturbance. Sleep Med. 2019;54:262–265.
   PubMed Web of Science ®Google Scholar
• Kaneko I, Sabir MS, Dussik CM, et al. 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. FASEB J Off Publ Fed Am Soc Exp Biol. 2015;29(9):4023–4035.
   PubMed Web of Science ®Google Scholar
• McCarty DE, Chesson ALJ, Jain SK, et al. The link between vitamin D metabolism and sleep medicine. Sleep Med Rev. 2014;18(4):311–319.
   PubMed Web of Science ®Google Scholar
• Massa J, Stone KL, Wei EK, et al. Vitamin D and actigraphic sleep outcomes in older community-dwelling men: the MrOS sleep study. Sleep. 2015;38(2):251–257.
   PubMed Web of Science ®Google Scholar
• Bertisch SM, Sillau S, de Boer IH, et al. 25-Hydroxyvitamin D Concentration and sleep duration and continuity: multi-ethnic study of atherosclerosis. Sleep. 2015 1;38(8):1305–1311.
   PubMed Web of Science ®Google Scholar
• Jung YS, Chae CH, Kim YO, et al. The relationship between serum vitamin D levels and sleep quality in fixed day indoor field workers in the electronics manufacturing industry in Korea. Ann Occup Environ Med. 2017;29:25.
   PubMed Web of Science ®Google Scholar
• Huang W, Shah S, Long Q, et al. Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation. Clin J Pain. 2013;29(4):341–347.
   PubMed Web of Science ®Google Scholar
• Gong Q-H, Li S-X, Li H, et al. 25-Hydroxyvitamin D Status and its association with sleep duration in chinese schoolchildren. Nutrients. 2018 3;10(8).
   Web of Science ®Google Scholar
• Yong CY, Reynaud E, Forhan A, et al. Cord-blood vitamin D level and night sleep duration in preschoolers in the EDEN mother-child birth cohort. Sleep Med. 2019;53:70–74.
   PubMed Web of Science ®Google Scholar
• Gominak SC, Stumpf WE. The world epidemic of sleep disorders is linked to vitamin D deficiency. Med Hypotheses. 2012;79(2):132–135.
   PubMed Web of Science ®Google Scholar
• Frase L, Nissen C, Riemann D, et al. Making sleep easier: pharmacological interventions for insomnia. Expert Opin Pharmacother. 2018;19(13):1465–1473.
   PubMed Web of Science ®Google Scholar
• Bruni O, Sette S, Angriman M, et al. Clinically oriented subtyping of chronic insomnia of childhood. J Pediatr. 2018;196:194–200.e1.
   PubMed Web of Science ®Google Scholar
• Bruni O, Angriman M, Calisti F, et al. Practitioner review: treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities. J Child Psychol Psychiatry. 2018;59(5):489–508.
   PubMed Web of Science ®Google Scholar